Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2018 | The limitation of applying biomarkers in clinical practice

Toni Choueiri • 9 Nov 2018
ESMO 2018
General Ipilimumab Nivolumab

In this video, Toni Choueiri, MD, of the Dana-Farber Cancer Institute, Boston, MA, highlights a major limitation of biomarkers. Prof. Choueiri uses examples of previously applied biomarkers to demonstrate the challenge of applying biomarkers clinically and practically, arguing that biomarkers have not yet had a significant impact on clinical judgement. This video was recorded at the European Society for Medical Oncology (ESMO) 2018 Congress, in Munich, Germany.

More from Toni Choueiri

What to look forward to in GU cancers at ESMO 2025
1:09
What to look forward to in GU cancers at ESMO 2025
Toni Choueiri • 17 Oct 2025
CONTACT-303: primary PFS analysis of atezolizumab and cabozantinib in ccRCC
4:15
CONTACT-303: primary PFS analysis of atezolizumab and cabozantinib in ccRCC
Toni Choueiri • 22 May 2023
Genitourinary cancer updates at ASCO 2023
0:59
Genitourinary cancer updates at ASCO 2023
Toni Choueiri • 22 May 2023
Optimal therapy sequencing in kidney cancer
1:17
Optimal therapy sequencing in kidney cancer
Toni Choueiri • 22 May 2023

Related Videos

AI governance and validation in robotic cancer surgery
1:12
AI governance and validation in robotic cancer surgery
Marie Hanaoka • 1 Jul 2026
Does toxicity differ between patients treated with SABR for one versus five lesions?
0:39
Does toxicity differ between patients treated with SABR for one versus five lesions?
Robert Olson • 16 May 2026
5-year toxicity following SABR: insights from the SABR-5 trial
0:42
5-year toxicity following SABR: insights from the SABR-5 trial
Robert Olson • 16 May 2026
How should results from the SABR-5 trial guide future SABR studies?
1:05
How should results from the SABR-5 trial guide future SABR studies?
Robert Olson • 16 May 2026

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJOncology is intended for healthcare professionals